Senior Research Analyst
Naureen Quibria, Ph.D. is a Senior Equity Research Analyst covering the biotechnology industry at Maxim Group. Dr. Quibria served in various consulting roles, including most recently as a Business Analyst at Johns Hopkins Technology Ventures prior to joining Maxim. She began her career in equity research at H.C. Wainwright, followed by JMP Securities. She has conducted research at NIH, Beth Israel Deaconess Medical Center/Harvard Medical School and UCLA. Dr. Quibria received her Ph.D. in Cell Biology and Pathobiology from Columbia University and holds a Bachelor’s degree in biology from Bryn Mawr College.